Matthias Bodenstedt's Insider Trades & SAST Disclosures
Matthias Bodenstedt's most recent trade in MoonLake Immunotherapeutics - Ordinary Shares - Class A was a trade of 95,763 Class A ordinary shares, par value $0.0001 per share done . Disclosure was reported to the exchange on Feb. 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Matthias Bodenstedt.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MoonLake Immunotherapeutic... | Matthias Bodenstedt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 95,763 | 616,666 | - | 0 | Class A ordinary shares, par value $0.0001 per share | |
| MoonLake Immunotherapeutic... | Bodenstedt Matthias | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 59.22 per share. | 19 Dec 2023 | 94,736 | 526,167 | - | 59.2 | 5,610,266 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Matthias Bodenstedt | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 58.34 per share. | 19 Dec 2023 | 5,264 | 520,903 | - | 58.3 | 307,102 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Matthias Bodenstedt | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2023 | 410,796 | 0 | - | - | Class C ordinary shares, par value $0.0001 per share | |
| MoonLake Immunotherapeutic... | Matthias Bodenstedt | Chief Financial Officer | 05 Apr 2023 | 410,796 | 410,796 | - | - | Class A ordinary shares, par value $0.0001 per share | ||
| MoonLake Immunotherapeutic... | Matthias Bodenstedt | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2023 | 147,135 | 357,445 | - | - | Class C ordinary shares, par value $0.0001 per share | |
| MoonLake Immunotherapeutic... | Matthias Bodenstedt | Chief Financial Officer | 05 Apr 2023 | 147,135 | 557,931 | - | - | Class A ordinary shares, par value $0.0001 per share | ||
| MoonLake Immunotherapeutic... | Matthias Bodenstedt | Chief Financial Officer | 05 Apr 2023 | 12,212 | 0 | - | - | Common shares, par value CHF 0.10 per share, of MoonLake AG | ||
| MoonLake Immunotherapeutic... | Matthias Bodenstedt | Chief Financial Officer | 05 Apr 2023 | 4,374 | 10,626 | - | - | Common shares, par value CHF 0.10 per share, of MoonLake AG |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges